U.S. stem cell clinics boomed while FDA paused crackdownU.S. stem cell clinics boomed while FDA paused crackdownU.S. stem cell clinics boomed while FDA paused crackdown

U.S. stem cell clinics boomed while FDA paused crackdown

The continuing spread of for-profit clinics promoting stem cells and other so-called “regenerative” therapies — including concentrated blood products — illustrates how quickly experimental medicine can outpace government oversight. 

from Section Page News - Modern Healthcare https://ift.tt/3F2Yztz